Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT01999985 · COMPLETED
Trial details
- NCT number
- NCT01999985
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-31
- Primary completion
- 2017-03-21
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.